Cansino Biologics (China) Performance
| 688185 Stock | 65.28 0.10 0.15% |
The firm shows a Beta (market volatility) of 0.31, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cansino Biologics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cansino Biologics is expected to be smaller as well. At this point, Cansino Biologics has a negative expected return of -0.42%. Please make sure to confirm Cansino Biologics' jensen alpha, treynor ratio, and the relationship between the information ratio and total risk alpha , to decide if Cansino Biologics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Cansino Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Ex Dividend Date 2022-08-23 |
1 | Bearish Setup How CanSino Biologics Inc. stock compares with tech leaders - Market Activity Summary Weekly Top Gainers Alerts - nchmf.gov.vn | 10/20/2025 |
2 | What analysts say about CanSino Biologics Inc CJH stock - Sector Leadership Analysis Analyze Your Portfolio Risk in Seconds - earlytimes.in | 12/02/2025 |
| Begin Period Cash Flow | 2 B | |
| Total Cashflows From Investing Activities | 4 M |
Cansino |
Cansino Biologics Relative Risk vs. Return Landscape
If you would invest 8,452 in Cansino Biologics on September 14, 2025 and sell it today you would lose (1,924) from holding Cansino Biologics or give up 22.76% of portfolio value over 90 days. Cansino Biologics is generating negative expected returns and assumes 1.7528% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than Cansino, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Cansino Biologics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cansino Biologics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cansino Biologics, and traders can use it to determine the average amount a Cansino Biologics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2406
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 688185 |
Estimated Market Risk
| 1.75 actual daily | 15 85% of assets are more volatile |
Expected Return
| -0.42 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.24 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cansino Biologics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cansino Biologics by adding Cansino Biologics to a well-diversified portfolio.
Cansino Biologics Fundamentals Growth
Cansino Stock prices reflect investors' perceptions of the future prospects and financial health of Cansino Biologics, and Cansino Biologics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cansino Stock performance.
| Return On Equity | -0.0284 | ||||
| Return On Asset | -0.0187 | ||||
| Profit Margin | (0.15) % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 10.67 B | ||||
| Shares Outstanding | 114.37 M | ||||
| Price To Book | 3.27 X | ||||
| Price To Sales | 16.59 X | ||||
| Revenue | 846.34 M | ||||
| Gross Profit | 721.5 M | ||||
| EBITDA | (193.95 M) | ||||
| Net Income | (378.88 M) | ||||
| Total Debt | 2.01 B | ||||
| Book Value Per Share | 27.01 X | ||||
| Cash Flow From Operations | (168.79 M) | ||||
| Earnings Per Share | (0.67) X | ||||
| Total Asset | 7.96 B | ||||
| Retained Earnings | (1.94 B) | ||||
About Cansino Biologics Performance
By analyzing Cansino Biologics' fundamental ratios, stakeholders can gain valuable insights into Cansino Biologics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cansino Biologics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cansino Biologics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Cansino Biologics is entity of China. It is traded as Stock on SHG exchange.Things to note about Cansino Biologics performance evaluation
Checking the ongoing alerts about Cansino Biologics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cansino Biologics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cansino Biologics generated a negative expected return over the last 90 days | |
| The company reported the revenue of 846.34 M. Net Loss for the year was (378.88 M) with profit before overhead, payroll, taxes, and interest of 721.5 M. | |
| Cansino Biologics generates negative cash flow from operations | |
| About 68.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: What analysts say about CanSino Biologics Inc CJH stock - Sector Leadership Analysis Analyze Your Portfolio Risk in Seconds - earlytimes.in |
- Analyzing Cansino Biologics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cansino Biologics' stock is overvalued or undervalued compared to its peers.
- Examining Cansino Biologics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cansino Biologics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cansino Biologics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cansino Biologics' stock. These opinions can provide insight into Cansino Biologics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Cansino Stock analysis
When running Cansino Biologics' price analysis, check to measure Cansino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cansino Biologics is operating at the current time. Most of Cansino Biologics' value examination focuses on studying past and present price action to predict the probability of Cansino Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cansino Biologics' price. Additionally, you may evaluate how the addition of Cansino Biologics to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |